Press-release for stocks related to n/a for novo nordisk a/s

Prices are updated after-hours

tags : N::A entities : Novo nordisk a::S

save search

Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
Published: 2024-04-15 (Crawled : 18:00) - globenewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -0.49% | O: 1.04% H: 0.19% C: -1.52%

Novo Nordisk A/S - share repurchase programme
Published: 2024-04-15 (Crawled : 13:00) - globenewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -0.49% | O: 1.04% H: 0.19% C: -1.52%
repurchase

Novo Nordisk A/S - share repurchase programme
Published: 2024-04-08 (Crawled : 13:30) - globenewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -0.86% | O: 1.62% H: 0.5% C: 0.36%
repurchase

REDUCED secures EUR 6 million financing led by Novo Holdings to scale its natural food ingredients business
Published: 2024-04-04 (Crawled : 06:00) - prnewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -1.29% | O: 1.1% H: 0.46% C: -2.32%
business natural million food

2023 Novo Holdings Asia Investments Annual Review/Business Update
Published: 2024-04-03 (Crawled : 07:00) - prnewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -2.02% | O: -0.75% H: 0.0% C: 0.0%
investments update asia

Novo Nordisk A/S - share repurchase programme
Published: 2024-04-02 (Crawled : 11:00) - globenewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -2.86% | O: -1.96% H: 1.3% C: 1.13%
repurchase

Novo Nordisk A/S - share repurchase programme
Published: 2024-03-25 (Crawled : 12:00) - globenewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -3.77% | O: 0.19% H: 0.97% C: 0.04%
repurchase

Novo Nordisk to acquire Cardior Pharmaceuticals and strengthen pipeline in cardiovascular disease
Published: 2024-03-25 (Crawled : 10:00) - globenewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -3.77% | O: 0.19% H: 0.97% C: 0.04%
disease pipeline pharmaceuticals acquire cardiovascular

Novo Nordisk A/S - Articles of Association 2024
Published: 2024-03-25 (Crawled : 08:00) - globenewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -3.77% | O: 0.19% H: 0.97% C: 0.04%
association

Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
Published: 2024-03-21 (Crawled : 16:00) - globenewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -4.96% | O: -1.04% H: 1.6% C: 0.64%
awiqli approval treatment diabetes insulin

Resolutions from the Annual General Meeting of Novo Nordisk A/S
Published: 2024-03-21 (Crawled : 15:00) - globenewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -4.96% | O: -1.04% H: 1.6% C: 0.64%
meeting

Novo Nordisk A/S - share repurchase programme
Published: 2024-03-18 (Crawled : 14:00) - globenewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -6.4% | O: -0.6% H: 1.66% C: 1.0%
repurchase

2023 Novo Holdings Bioindustrial Investments Team Annual Review/Business Update
Published: 2024-03-15 (Crawled : 09:00) - prnewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -7.94% | O: -0.52% H: 0.09% C: -1.13%
investments update

Novo Holdings Portfolio Company Amolyt Pharma Enters into Definitive Agreement to be Acquired by AstraZeneca
Published: 2024-03-14 (Crawled : 08:00) - prnewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -7.18% | O: 1.77% H: 0.05% C: -0.93%
pharma company astrazeneca acquired agreement

Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
Published: 2024-03-13 (Crawled : 18:00) - prnewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -8.3% | O: -0.64% H: 0.94% C: -0.56%
JNJ | $147.59 0.05% -0.56% 72K

Health Technology

| -8.56% | O: 0.66% H: 0.0% C: 0.0%
LLY | $750.77 -0.12% 0.38% 16K

Health Technology

| -0.55% | O: 0.27% H: 0.5% C: 0.11%
ABT | $108.89 -0.2% 0.28% 3.4M

Health Technology

| -9.39% | O: 0.41% H: 0.0% C: 0.0%
SNY | $46.24 0.68% 0.63% 0

Health Technology

| -3.04% | O: -0.04% H: 0.0% C: 0.0%
report distribution year global market

Novo Holdings reports Total Income and Investment Returns of DKK 31 billion (€4.2 billion) for 2023. Total Assets grow by 38% to DKK 1,114 billion (€149 billion)
Published: 2024-03-12 (Crawled : 07:00) - prnewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -5.59% | O: 0.27% H: 2.67% C: 2.67%
total

Novo Nordisk A/S - share repurchase programme
Published: 2024-03-11 (Crawled : 13:00) - globenewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -6.89% | O: 0.23% H: 0.11% C: -1.6%
repurchase

FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight
Published: 2024-03-08 (Crawled : 20:00) - prnewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| Email alert Add to watchlist
fda obesity first treatment risk heart

Wegovy® approved in the US for cardiovascular risk reduction in people with overweight or obesity and established cardiovascular disease
Published: 2024-03-08 (Crawled : 19:00) - globenewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| Email alert Add to watchlist
wegovy obesity disease approved risk cardiovascular

Highlights to be presented at Novo Nordisk’s Capital Markets Day 2024
Published: 2024-03-07 (Crawled : 07:00) - globenewswire.com
NVO | $123.9 -0.49% -0.69% 20K

Health Technology

| -0.68% | O: 6.97% H: 3.63% C: 1.86%
day